MedTrace Logo

Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer

NCT04370522 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2026-05-05

No results posted yet for this study

Summary

This is a multicentre, prospective, observational, no post-authorization study. This study will be opened for recruitment approximately for 12 months for a pilot phase including at least 25-30 patients and 6 controls and for 12 additional months to complete patient and control inclusion until 90 patients and 20 control depending on the first part study results.

Conditions

Sponsors & Collaborators

  • Spanish Breast Cancer Research Group

    lead OTHER

Principal Investigators

  • Study Director · Hospital General Universitario Morales Meseguer

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-21
Primary Completion
2025-03-24
Completion
2025-03-24

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04370522 on ClinicalTrials.gov